Uplizna (inebilizumab) National Broadcast Event
Prime & Pearl
4949 Celebration Pointe Avenue
Gainesville, FL 32608
Wednesday, February 25, 2026 at 6:30pm ET - 8:00pm ET
Info
Additional Information
UPLIZNA, the first and only FDA-approved CD-19 targeted therapy for the treatment of Adults with Anti-AChR or Anti-MuSK antibody positive General Myasthenia Gravis (gMG).
*Registration: RSVP Cheryl Kennedy via email ckenne01@amgen.com
Speakers
Amanda Hernandez
MD, PhD
University of Connecticut
Gil Wolfe
MD, FAAN
SUNY Distinguished Professor of Neurology at University at Buffalo Co-Director, MDA Clinics and Neuromuscular Section Chief of Service for Neurology, Kaleida Health System